Navigation Links
Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity
Date:6/1/2008

Improvement Noted in Management of Transplant Recipients with Cancer

HERSHEY, Pa., June 1 /PRNewswire/ -- The management of immunosuppression in post-transplant patients with cancer is challenging. Clinicians must balance the need to treat the malignancy effectively while simultaneously monitoring the impact of chemotherapeutic agents on a patient's immune system.

Data relevant to improving management of such patients will be presented today at the American Transplant Congress in Toronto, Canada, from a cooperative study conducted by the Departments of Surgery and Pathology and the Division of Internal Medicine, Department of Medicine at the Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania.

Tadahiro Uemura, M.D., Ph.D. and his colleagues studied the immunosuppression status of 52 patients with post-transplant de novo malignancy, assessing the cell-mediated immunity of patients by taking advantage of the ability of the Cylex immune cell function assay (ImmuKnow(R)). They compared outcomes of patients who were and were not monitored using this assay over a follow-up period of nine months post-transplant. Their paper is entitled "Monitoring of immune function for treatment of post-transplant de novo malignancy." The 52 patients included 40 kidney transplants, 10 liver transplants, and two kidney and pancreas transplants. Uemura is an assistant professor, Division of Transplantation in the Department of Surgery at Penn State Hershey Medical Center.

The ImmuKnow cell function test measures cell-mediated immunity (CMI) by assaying the concentration of adenosine triphosphate (ATP) from CD4 cells following stimulation. The assay is intended for use in the detection of CMI in an immunosuppressed population.

According to Uemura and his collaborators, in patients previously diagnosed with cancer, levels of CMI were more precisely targeted toward 340 ng ATP/ml (within the "moderate" range of the ImmuKnow assay). Howe
'/>"/>

SOURCE Penn State Milton S. Hershey Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
2. Prostate Cancer Treatment Offers Results Without Side Effects
3. New Gene Methylation Test for Prostate Cancer Available
4. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
5. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
6. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
7. Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Mens Health Week Is June 9-15)
8. Alabama Hospitals Compare Infection Prevention Performance Statewide With New Benchmarking Tool
9. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
10. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
11. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Wash. , Dec. 19, 2014  Advanced ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that a Life ... has been awarded for which AMIC is the ... State University (WSU) for the proposal titled "Optimized ...
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... marketplace, innovative consumer research and marketing communication tools ... rich and globally competitive – consequently consumers, desires, ... In this environment, market research groups across ... research and marketing communication tools. However, the adoption ...
(Date:12/19/2014)... Dec. 18, 2014 Somewhere between dropping five ... was forgotten. But Audicus , a next-generation hearing ... this new year. Hearing loss is the ... population, though it is often unaddressed. Forty-eight million Americans ... a hearing aid, mainly due to price. Hearing aids ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Audicus Will Help People Resolve to Hear Better in 2015 2
... /PRNewswire-FirstCall/ --,Genta Incorporated announced the presentation of ... its marketed product, Ganite(R) (gallium,nitrate injection), plus ... relapsed or refractory non-Hodgkin's,lymphoma (NHL). The data ... American Society of Clinical Oncology (ASCO) in ...
... in 35% of HER2-Positive Metastatic Breast,Cancer ... /PRNewswire-FirstCall/ -- Kosan,Biosciences Incorporated presented data ... that alvespimycin, its second-generation Hsp90,inhibitor, demonstrated ... with trastuzumab (Herceptin(R)) in,patients with refractory ...
Cached Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 2Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 3Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 4Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 5Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO 6
(Date:12/21/2014)... 2014 Parker & Sons, Inc. a ... plumbing and other similar home contractor services announces a ... to its expert contracting services. The company is considered ... been serving Arizona for well over 40 years. Parker ... best in quality customer service to the residents and ...
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at the ... its kind, the site has provided its faithful users with ... running. It uniquely combines the benefits of platforms like ... to the masses. Assuring the potent herb’s followers it’s ... public approval. , Shane Chattin, Owner of Cannabis ...
(Date:12/20/2014)... December 21, 2014 MissyDress, a distinguished ... all prom lovers. The business has drastically cut prices ... dresses to everyone until Jan. 30, 2015. Many of ... sweetheart dresses, V-neck dresses, lace dresses, and more. , ... not there every day. Whether A-line princess prom dresses ...
(Date:12/20/2014)... print component of Healthy Aging is distributed within today’s ... and an estimated readership of 420,000. The digital component ... and across a network of top news sites and ... campaign, click here . , The publication features ... The Social. Lainey Lui, Melissa Grelo, Traci Melchor, ...
(Date:12/20/2014)... 2014 As Risperdal lawsuits ( ... U.S. courts, Bernstein Liebhard LLP notes the publication ... treated with the medication may experience elevated levels ... and lactation. The study, which appears in International ... who began treatment with risperidone, an antipsychotic medication ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4
... Funding Suspension After Trial Failures, WASHINGTON, ... piece today ( http://www.baltimoresun.com/news/opinion/oped/bal -,op.aidsvaccine23mar23,0,3426636.story), AIDS Healthcare ... HIV vaccine research funding and the,re- allocation ... and treatment strategies., Co-authored by Dr. ...
... can shield children from harm , , SATURDAY, March 22 ... which concludes Saturday, the Soap and Detergent Association offers ... , Parents and caregivers should: , Install child-safety ... chemicals and other poisons. Never assume a cabinet is ...
... But it,s not too late to protect yourself and ... News) -- News from the diabetes front seems to ... the disease, fueled by obesity and sedentary lifestyles, have ... affecting about 7 percent of the population. That,s an ...
... N.C., March 21 A CI head once noted ... it, but the only,time you realize you need it ... today,s marketing space, most companies need competitive,intelligence to effectively ... key insights are lacking that people begin to realize ...
... are small, the trend is worrisome, study says ... small, but worrisome number of facelift patients became ... MRSA, a new study reports. , About one ... developed the so-called "superbug" methicillin-resistant Staphylococcus aureus ...
... and genetic testing, study shows , , FRIDAY, March ... discuss a family,s cancer history has a major impact ... women at moderate risk for breast cancer, according to ... black women are less likely than white women ...
Cached Medicine News:Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 2Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 3Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 4Health News:Poison Prevention Tips to Protect the Most Vulnerable 2Health News:Diabetes' Toll Continues to Grow 2Health News:Diabetes' Toll Continues to Grow 3Health News:Diabetes' Toll Continues to Grow 4Health News:New Research Uncovers How to Build and Maintain an Effective Competitive Intelligence Group 2Health News:Some Facelift Patients Infected With MRSA 'Superbug' 2Health News:Some Facelift Patients Infected With MRSA 'Superbug' 3Health News:Family Discussion Plays Role in Breast Cancer Awareness 2
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Nerve Electrodes provide direct cranial nerve ... patented circumferential design provides sensitive contact ... stable real-time recordings. This unique approach ... the removal of acoustic neuromas, microvascular ...
... Ad-Techs Model CMU Cortical Mapping Unit ... of recording EEGs from exposed cortex during ... each electrode plate can be positioned independently ... clamp provides two alternative mounting locations and ...
An ambulatory recorder can help the patient be more comfortable and at ease as well as increasing an EEG laboratory's recording capacity....
Medicine Products: